Symbols / INSP Stock $56.31 -0.07% Inspire Medical Systems, Inc.
INSP (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-15 | main | Truist Securities | Hold → Hold | $64 |
| 2026-04-13 | main | Mizuho | Outperform → Outperform | $70 |
| 2026-04-10 | main | Stifel | Buy → Buy | $70 |
| 2026-04-06 | main | Evercore ISI Group | Outperform → Outperform | $62 |
| 2026-03-05 | main | Stifel | Buy → Buy | $85 |
| 2026-02-13 | down | Wolfe Research | Outperform → Peer Perform | — |
| 2026-02-12 | main | Jefferies | Hold → Hold | $66 |
| 2026-02-12 | main | RBC Capital | Sector Perform → Sector Perform | $68 |
| 2026-02-12 | main | Piper Sandler | Overweight → Overweight | $85 |
| 2026-02-12 | main | Truist Securities | Hold → Hold | $70 |
| 2026-02-12 | main | Mizuho | Outperform → Outperform | $85 |
| 2026-02-12 | down | Wells Fargo | Overweight → Equal-Weight | $70 |
| 2026-02-12 | down | Baird | Outperform → Neutral | $74 |
| 2026-01-27 | down | RBC Capital | Outperform → Sector Perform | $90 |
| 2026-01-14 | main | Wells Fargo | Overweight → Overweight | $145 |
| 2026-01-08 | main | Truist Securities | Buy → Buy | $120 |
| 2025-12-23 | main | UBS | Neutral → Neutral | $91 |
| 2025-12-17 | main | RBC Capital | Outperform → Outperform | $175 |
| 2025-12-17 | main | Mizuho | Outperform → Outperform | $130 |
| 2025-12-16 | main | JP Morgan | Neutral → Neutral | $118 |
- A Look At Inspire Medical Systems (INSP) Valuation After Recent Share Price Reset - simplywall.st Fri, 24 Apr 2026 09
- Inspire Medical Systems, Inc. (INSP) PT Reduced to $64 as Truist Updates MedTech Outlook Ahead of Q1 - Yahoo Finance Fri, 24 Apr 2026 13
- Inspire Medical Systems Inc (INSP) Stock Up 4.2% and Still Under - GuruFocus Wed, 22 Apr 2026 23
- Inspire Medical Systems (NYSE:INSP) Shares Down 8.3% - Time to Sell? - MarketBeat ue, 21 Apr 2026 17
- Inspire Medical Systems, Inc. (INSP) Stock Analysis: 25% Potential Upside Beckons Investors - DirectorsTalk Interviews Mon, 20 Apr 2026 09
- Inspire Medical Systems Stock Rebounds 15%: What Q4 Profit Growth Means for 2026 - TIKR.com Fri, 27 Feb 2026 08
- Here's why you should add Inspire Medical stock to your portfolio now - MSN hu, 23 Apr 2026 14
- INSP (Inspire Medical Systems Inc.) Q4 2025 EPS beats estimates by wide margin even as shares dip slightly today. - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 03
- INSP 260515 45.00P (INSP260515P45000) Stock Options Chain | Quotes & News - Moomoo Wed, 22 Apr 2026 01
- Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Yahoo Finance Fri, 27 Feb 2026 08
- Inspire Medical Systems Governance Vote Arrives As Shares Trade Below Targets - simplywall.st hu, 26 Mar 2026 07
- Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Yahoo Finance hu, 22 Jan 2026 08
- Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Yahoo Finance hu, 22 Jan 2026 08
- Here's Why You Should Retain INSP Stock in Your Portfolio Now - Yahoo Finance Mon, 22 Dec 2025 08
- Inspire Medical Systems (INSP) Stock Trades Up, Here Is Why - Yahoo Finance Mon, 08 Dec 2025 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
911.98
+13.60%
|
802.80
+28.49%
|
624.80
+53.19%
|
407.86
|
| Operating Revenue |
|
911.98
+13.60%
|
802.80
+28.49%
|
624.80
+53.19%
|
407.86
|
| Cost Of Revenue |
|
133.22
+8.33%
|
122.99
+27.35%
|
96.58
+46.07%
|
66.11
|
| Reconciled Cost Of Revenue |
|
133.22
+8.33%
|
122.99
+27.35%
|
96.58
+46.07%
|
66.11
|
| Gross Profit |
|
778.76
+14.55%
|
679.82
+28.70%
|
528.22
+54.57%
|
341.74
|
| Operating Expense |
|
727.80
+13.06%
|
643.74
+13.24%
|
568.49
+46.02%
|
389.33
|
| Research And Development |
|
103.17
-9.61%
|
114.13
-2.07%
|
116.54
+69.77%
|
68.64
|
| Selling General And Administration |
|
624.64
+17.94%
|
529.61
+17.18%
|
451.96
+40.93%
|
320.69
|
| Total Expenses |
|
861.03
+12.30%
|
766.72
+15.28%
|
665.07
+46.03%
|
455.45
|
| Operating Income |
|
50.95
+41.21%
|
36.08
+189.60%
|
-40.27
+15.38%
|
-47.59
|
| Total Operating Income As Reported |
|
50.95
+41.21%
|
36.08
+189.60%
|
-40.27
+15.38%
|
-47.59
|
| EBITDA |
|
79.79
+22.71%
|
65.03
+481.15%
|
-17.06
+58.12%
|
-40.73
|
| Normalized EBITDA |
|
79.79
+22.71%
|
65.03
+481.15%
|
-17.06
+58.12%
|
-40.73
|
| Reconciled Depreciation |
|
13.96
+113.08%
|
6.55
+130.15%
|
2.85
+53.18%
|
1.86
|
| EBIT |
|
65.83
+12.58%
|
58.48
+393.76%
|
-19.91
+53.26%
|
-42.59
|
| Net Income |
|
145.42
+171.77%
|
53.51
+352.96%
|
-21.15
+52.87%
|
-44.88
|
| Pretax Income |
|
65.70
+12.39%
|
58.45
+393.65%
|
-19.91
+55.03%
|
-44.27
|
| Net Non Operating Interest Income Expense |
|
17.40
-25.09%
|
23.23
+12.96%
|
20.56
+509.55%
|
3.37
|
| Interest Expense Non Operating |
|
0.14
+522.73%
|
0.02
|
0.00
-100.00%
|
1.68
|
| Net Interest Income |
|
17.40
-25.09%
|
23.23
+12.96%
|
20.56
+509.55%
|
3.37
|
| Interest Expense |
|
0.14
+522.73%
|
0.02
|
0.00
-100.00%
|
1.68
|
| Interest Income Non Operating |
|
17.54
-24.57%
|
23.25
+13.07%
|
20.56
+307.13%
|
5.05
|
| Interest Income |
|
17.54
-24.57%
|
23.25
+13.07%
|
20.56
+307.13%
|
5.05
|
| Other Income Expense |
|
-2.66
-210.64%
|
-0.85
-338.46%
|
-0.20
-297.96%
|
-0.05
|
| Other Non Operating Income Expenses |
|
-2.66
-210.64%
|
-0.85
-338.46%
|
-0.20
-297.96%
|
-0.05
|
| Tax Provision |
|
-79.72
-1712.56%
|
4.94
+296.47%
|
1.25
+103.43%
|
0.61
|
| Tax Rate For Calcs |
|
0.00
+148.28%
|
0.00
-59.72%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
145.42
+171.77%
|
53.51
+352.96%
|
-21.15
+52.87%
|
-44.88
|
| Net Income From Continuing Operation Net Minority Interest |
|
145.42
+171.77%
|
53.51
+352.96%
|
-21.15
+52.87%
|
-44.88
|
| Net Income From Continuing And Discontinued Operation |
|
145.42
+171.77%
|
53.51
+352.96%
|
-21.15
+52.87%
|
-44.88
|
| Net Income Continuous Operations |
|
145.42
+171.77%
|
53.51
+352.96%
|
-21.15
+52.87%
|
-44.88
|
| Normalized Income |
|
145.42
+171.77%
|
53.51
+352.96%
|
-21.15
+52.87%
|
-44.88
|
| Net Income Common Stockholders |
|
145.42
+171.77%
|
53.51
+352.96%
|
-21.15
+52.87%
|
-44.88
|
| Diluted EPS |
|
—
|
1.75
+343.06%
|
-0.72
+55.00%
|
-1.60
|
| Basic EPS |
|
—
|
1.80
+350.00%
|
-0.72
+55.00%
|
-1.60
|
| Basic Average Shares |
|
—
|
29.76
+1.57%
|
29.30
+4.38%
|
28.07
|
| Diluted Average Shares |
|
—
|
29.76
+1.57%
|
29.30
+4.38%
|
28.07
|
| Diluted NI Availto Com Stockholders |
|
145.42
+171.77%
|
53.51
+352.96%
|
-21.15
+52.87%
|
-44.88
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
907.32
+12.24%
|
808.38
+19.44%
|
676.81
+19.82%
|
564.88
|
| Current Assets |
|
583.65
-7.48%
|
630.81
+6.24%
|
593.74
+12.02%
|
530.03
|
| Cash Cash Equivalents And Short Term Investments |
|
308.27
-30.81%
|
445.55
-3.22%
|
460.38
+1.99%
|
451.41
|
| Cash And Cash Equivalents |
|
104.81
-30.19%
|
150.15
-19.07%
|
185.54
-57.98%
|
441.59
|
| Other Short Term Investments |
|
203.46
-31.12%
|
295.40
+7.48%
|
274.84
+2698.47%
|
9.82
|
| Receivables |
|
119.69
+28.61%
|
93.07
+3.54%
|
89.88
+46.80%
|
61.23
|
| Accounts Receivable |
|
119.69
+28.61%
|
93.07
+3.54%
|
89.88
+46.80%
|
61.23
|
| Gross Accounts Receivable |
|
120.77
+28.55%
|
93.95
+2.64%
|
91.53
+49.41%
|
61.26
|
| Allowance For Doubtful Accounts Receivable |
|
-1.08
-22.73%
|
-0.88
+46.60%
|
-1.65
-4477.78%
|
-0.04
|
| Inventory |
|
145.29
+81.35%
|
80.12
+136.44%
|
33.88
+185.08%
|
11.89
|
| Raw Materials |
|
19.10
-14.86%
|
22.43
+266.80%
|
6.12
+8.33%
|
5.64
|
| Work In Process |
|
13.84
|
0.00
|
—
|
—
|
| Finished Goods |
|
112.36
+94.77%
|
57.69
+107.73%
|
27.77
+344.96%
|
6.24
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
10.40
-13.87%
|
12.07
+25.84%
|
9.60
+74.30%
|
5.50
|
| Total Non Current Assets |
|
323.67
+82.27%
|
177.58
+113.76%
|
83.07
+138.41%
|
34.84
|
| Net PPE |
|
121.40
+27.47%
|
95.24
+52.02%
|
62.65
+159.65%
|
24.13
|
| Gross PPE |
|
147.05
+34.92%
|
109.00
+55.88%
|
69.92
+140.79%
|
29.04
|
| Accumulated Depreciation |
|
-25.65
-86.44%
|
-13.76
-89.22%
|
-7.27
-48.09%
|
-4.91
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
23.53
+0.94%
|
23.31
+2.85%
|
22.67
+229.46%
|
6.88
|
| Machinery Furniture Equipment |
|
33.17
+100.37%
|
16.55
+629.21%
|
2.27
+31.29%
|
1.73
|
| Construction In Progress |
|
24.38
-2.38%
|
24.98
-24.80%
|
33.21
+180.10%
|
11.86
|
| Other Properties |
|
54.21
+58.97%
|
34.10
+262.05%
|
9.42
+44.69%
|
6.51
|
| Leases |
|
11.77
+17.01%
|
10.06
+326.87%
|
2.36
+14.15%
|
2.06
|
| Investments And Advances |
|
96.33
+35.69%
|
71.00
+676.50%
|
9.14
|
0.00
|
| Non Current Deferred Assets |
|
88.67
+681953.85%
|
0.01
|
—
|
—
|
| Non Current Deferred Taxes Assets |
|
88.67
+681953.85%
|
0.01
|
—
|
—
|
| Other Non Current Assets |
|
17.26
+52.37%
|
11.33
+0.46%
|
11.28
+5.25%
|
10.71
|
| Total Liabilities Net Minority Interest |
|
126.16
+6.29%
|
118.69
+13.80%
|
104.30
+51.44%
|
68.87
|
| Current Liabilities |
|
96.06
+8.54%
|
88.50
+13.31%
|
78.11
+27.65%
|
61.19
|
| Payables And Accrued Expenses |
|
93.90
+8.24%
|
86.75
+11.06%
|
78.11
+30.50%
|
59.85
|
| Payables |
|
39.02
-3.18%
|
40.30
+2.24%
|
39.42
+46.82%
|
26.85
|
| Accounts Payable |
|
36.56
-5.49%
|
38.69
-0.39%
|
38.84
+44.67%
|
26.85
|
| Current Accrued Expenses |
|
54.88
+18.16%
|
46.45
+20.05%
|
38.69
+17.23%
|
33.00
|
| Total Tax Payable |
|
2.45
+52.11%
|
1.61
+179.38%
|
0.58
|
—
|
| Income Tax Payable |
|
2.45
+52.11%
|
1.61
+179.38%
|
0.58
|
—
|
| Current Debt And Capital Lease Obligation |
|
2.16
+22.98%
|
1.75
|
—
|
1.34
|
| Current Debt |
|
—
|
—
|
—
|
—
|
| Other Current Borrowings |
|
—
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
2.16
+22.98%
|
1.75
|
0.00
-100.00%
|
1.34
|
| Total Non Current Liabilities Net Minority Interest |
|
30.10
-0.28%
|
30.19
+15.25%
|
26.19
+240.95%
|
7.68
|
| Long Term Debt And Capital Lease Obligation |
|
30.00
-0.14%
|
30.04
+20.90%
|
24.85
+229.70%
|
7.54
|
| Long Term Debt |
|
—
|
—
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
30.00
-0.14%
|
30.04
+20.90%
|
24.85
+229.70%
|
7.54
|
| Other Non Current Liabilities |
|
0.10
-29.73%
|
0.15
-89.00%
|
1.35
+821.92%
|
0.15
|
| Stockholders Equity |
|
781.16
+13.26%
|
689.70
+20.47%
|
572.51
+15.42%
|
496.01
|
| Common Stock Equity |
|
781.16
+13.26%
|
689.70
+20.47%
|
572.51
+15.42%
|
496.01
|
| Capital Stock |
|
0.03
-3.33%
|
0.03
+0.00%
|
0.03
+3.45%
|
0.03
|
| Common Stock |
|
0.03
-3.33%
|
0.03
+0.00%
|
0.03
+3.45%
|
0.03
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
28.58
-3.90%
|
29.74
+0.61%
|
29.56
+1.90%
|
29.01
|
| Ordinary Shares Number |
|
28.58
-3.90%
|
29.74
+0.61%
|
29.56
+1.90%
|
29.01
|
| Additional Paid In Capital |
|
927.16
-5.49%
|
981.04
+6.97%
|
917.11
+11.80%
|
820.34
|
| Retained Earnings |
|
-146.49
+49.82%
|
-291.91
+15.49%
|
-345.42
-6.52%
|
-324.27
|
| Gains Losses Not Affecting Retained Earnings |
|
0.46
-13.43%
|
0.54
-33.00%
|
0.80
+1030.23%
|
-0.09
|
| Other Equity Adjustments |
|
0.46
-13.43%
|
0.54
-33.00%
|
0.80
+1030.23%
|
-0.09
|
| Total Equity Gross Minority Interest |
|
781.16
+13.26%
|
689.70
+20.47%
|
572.51
+15.42%
|
496.01
|
| Total Capitalization |
|
781.16
+13.26%
|
689.70
+20.47%
|
572.51
+15.42%
|
496.01
|
| Working Capital |
|
487.60
-10.09%
|
542.30
+5.17%
|
515.63
+9.98%
|
468.85
|
| Invested Capital |
|
781.16
+13.26%
|
689.70
+20.47%
|
572.51
+15.42%
|
496.01
|
| Total Debt |
|
32.16
+1.14%
|
31.79
+27.96%
|
24.85
+180.05%
|
8.87
|
| Capital Lease Obligations |
|
32.16
+1.14%
|
31.79
+27.96%
|
24.85
+180.05%
|
8.87
|
| Net Tangible Assets |
|
781.16
+13.26%
|
689.70
+20.47%
|
572.51
+15.42%
|
496.01
|
| Tangible Book Value |
|
781.16
+13.26%
|
689.70
+20.47%
|
572.51
+15.42%
|
496.01
|
| Available For Sale Securities |
|
96.33
+35.69%
|
71.00
+676.50%
|
9.14
|
—
|
| Interest Payable |
|
—
|
—
|
—
|
0.00
|
| Investmentin Financial Assets |
|
96.33
+35.69%
|
71.00
+676.50%
|
9.14
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
116.98
-10.19%
|
130.25
+428.32%
|
24.65
+113.10%
|
11.57
|
| Cash Flow From Continuing Operating Activities |
|
116.98
-10.19%
|
130.25
+428.32%
|
24.65
+113.10%
|
11.57
|
| Net Income From Continuing Operations |
|
145.42
+171.77%
|
53.51
+352.96%
|
-21.15
+52.87%
|
-44.88
|
| Depreciation Amortization Depletion |
|
13.96
+113.08%
|
6.55
+130.15%
|
2.85
+53.18%
|
1.86
|
| Depreciation And Amortization |
|
13.96
+113.08%
|
6.55
+130.15%
|
2.85
+53.18%
|
1.86
|
| Other Non Cash Items |
|
2.11
+39.16%
|
1.52
-28.71%
|
2.13
+142.09%
|
0.88
|
| Stock Based Compensation |
|
130.26
+12.29%
|
116.01
+40.67%
|
82.47
+58.69%
|
51.97
|
| Provisionand Write Offof Assets |
|
0.20
+126.04%
|
-0.77
-147.64%
|
1.61
+2658.73%
|
-0.06
|
| Asset Impairment Charge |
|
4.05
|
0.00
|
0.00
|
—
|
| Deferred Tax |
|
-88.75
|
0.00
|
0.00
|
—
|
| Deferred Income Tax |
|
-88.75
|
0.00
|
0.00
|
—
|
| Change In Working Capital |
|
-87.38
-131.72%
|
-37.71
+7.53%
|
-40.78
-2353.09%
|
1.81
|
| Change In Receivables |
|
-26.23
-908.19%
|
-2.60
+91.39%
|
-30.22
-11.85%
|
-27.02
|
| Changes In Account Receivables |
|
-26.23
-908.19%
|
-2.60
+91.39%
|
-30.22
-11.85%
|
-27.02
|
| Change In Inventory |
|
-65.17
-40.97%
|
-46.23
-110.16%
|
-22.00
-511.58%
|
5.34
|
| Change In Prepaid Assets |
|
1.65
+170.44%
|
-2.34
+50.74%
|
-4.76
-69.02%
|
-2.81
|
| Change In Payables And Accrued Expense |
|
2.38
-82.36%
|
13.47
-16.83%
|
16.19
-38.42%
|
26.30
|
| Change In Accrued Expense |
|
6.12
-52.41%
|
12.87
+86.50%
|
6.90
-42.24%
|
11.94
|
| Change In Payable |
|
-3.75
-720.36%
|
0.60
-93.50%
|
9.30
-35.24%
|
14.36
|
| Change In Account Payable |
|
-3.75
-720.36%
|
0.60
-93.50%
|
9.30
-35.24%
|
14.36
|
| Investing Cash Flow |
|
21.45
+118.96%
|
-113.12
+61.63%
|
-294.82
-1404.50%
|
-19.60
|
| Cash Flow From Continuing Investing Activities |
|
21.45
+118.96%
|
-113.12
+61.63%
|
-294.82
-1404.50%
|
-19.60
|
| Net PPE Purchase And Sale |
|
-38.50
+1.59%
|
-39.12
-65.57%
|
-23.63
-159.77%
|
-9.10
|
| Purchase Of PPE |
|
-38.50
+1.59%
|
-39.12
-65.57%
|
-23.63
-159.77%
|
-9.10
|
| Capital Expenditure |
|
-38.50
+1.59%
|
-39.12
-65.57%
|
-23.63
-159.77%
|
-9.10
|
| Net Investment Purchase And Sale |
|
59.95
+181.01%
|
-74.00
+72.71%
|
-271.19
-2482.79%
|
-10.50
|
| Purchase Of Investment |
|
-250.44
+40.17%
|
-418.60
-48.74%
|
-281.44
-2580.37%
|
-10.50
|
| Sale Of Investment |
|
310.38
-9.93%
|
344.61
+3263.31%
|
10.25
|
0.00
|
| Financing Cash Flow |
|
-183.45
-250.14%
|
-52.39
-475.58%
|
13.95
-94.07%
|
235.08
|
| Cash Flow From Continuing Financing Activities |
|
-183.45
-250.14%
|
-52.39
-475.58%
|
13.95
-94.07%
|
235.08
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
|
0.00
+100.00%
|
-24.50
|
| Repayment Of Debt |
|
—
|
0.00
|
0.00
+100.00%
|
-24.50
|
| Long Term Debt Payments |
|
—
|
0.00
|
0.00
+100.00%
|
-24.50
|
| Net Long Term Debt Issuance |
|
—
|
0.00
|
0.00
+100.00%
|
-24.50
|
| Net Common Stock Issuance |
|
-175.02
-133.36%
|
-75.00
|
0.00
-100.00%
|
243.80
|
| Common Stock Payments |
|
-175.02
-133.36%
|
-75.00
|
0.00
|
0.00
|
| Repurchase Of Capital Stock |
|
-175.02
-133.36%
|
-75.00
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
14.61
-47.38%
|
27.77
-10.72%
|
31.11
+96.65%
|
15.82
|
| Net Other Financing Charges |
|
-23.04
-346.16%
|
-5.17
+69.90%
|
-17.16
-39802.33%
|
-0.04
|
| Changes In Cash |
|
-45.03
-27.67%
|
-35.27
+86.23%
|
-256.22
-212.85%
|
227.05
|
| Effect Of Exchange Rate Changes |
|
-0.31
-162.71%
|
-0.12
-171.95%
|
0.16
+118.67%
|
0.07
|
| Beginning Cash Position |
|
150.15
-19.07%
|
185.54
-57.98%
|
441.59
+105.90%
|
214.47
|
| End Cash Position |
|
104.81
-30.19%
|
150.15
-19.07%
|
185.54
-57.98%
|
441.59
|
| Free Cash Flow |
|
78.48
-13.88%
|
91.12
+8798.73%
|
1.02
-58.59%
|
2.47
|
| Interest Paid Supplemental Data |
|
0.14
+522.73%
|
0.02
|
0.00
-100.00%
|
2.32
|
| Amortization Of Securities |
|
-2.89
+67.39%
|
-8.86
-258.81%
|
-2.47
-61625.00%
|
-0.00
|
| Common Stock Issuance |
|
—
|
0.00
|
0.00
-100.00%
|
243.80
|
| Issuance Of Capital Stock |
|
—
|
0.00
|
0.00
-100.00%
|
243.80
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-16 View
- 42026-04-16 View
- 42026-04-16 View
- 42026-04-16 View
- 42026-02-24 View
- 42026-02-24 View
- 42026-02-24 View
- 42026-02-24 View
- 42026-02-24 View
- 42026-02-24 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 10-K2026-02-13 View
- 42026-02-11 View
- 42026-02-11 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|